10 years ago, St. Jude took on pediatric cancer genome, and won

By , Daily Memphian Updated: February 12, 2020 1:20 PM CT | Published: February 10, 2020 4:00 AM CT
<strong>Dr. James Downing, president and CEO of St. Jude Children's Research Hospital, has been instrumental in the development and refinement of St. Jude's genomic sequencing operations for pediatric cancer.&nbsp;</strong>(Patrick Lantrip/Daily Memphian)

Dr. James Downing, president and CEO of St. Jude Children's Research Hospital, has been instrumental in the development and refinement of St. Jude's genomic sequencing operations for pediatric cancer. (Patrick Lantrip/Daily Memphian)

Among the findings was genetic coding that proved there is more than a passing chance that some cancers are inherited. 

Bluff City Biz

Sign up to get the latest news and analysis from our Business team.

Manage Your Email Subscriptions

Topics

Dr. James Downing St. Jude Children’s Research Hospital Pediatric Cancer Genome Project
Jane Roberts

Jane Roberts

Longtime journalist Jane Roberts is a Minnesotan by birth and a Memphian by choice. She's lived and reported in the city more than two decades. She covers healthcare and higher education for The Daily Memphian.


Comment On This Story

Become a subscriber to join the discussion.
Bluff City Biz

Sign up to get the latest news and analysis from our Business team.

Manage Your Email Subscriptions